Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-State, Tribal, Local and Territorial (STLT) Subcommittee, 29088 [2017-13339]

Download as PDF 29088 Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK30JT082PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: TIME AND DATE: 8:30 a.m.–3:30 p.m., EDT, August 11, 2017. PLACE: CDC, Building 19, Rooms 245– 246, 1600 Clifton Road, NE., Atlanta, Georgia 30329. This meeting will also be held by teleconference. STATUS: Open to the public, limited only by the space available. The meeting room accommodates approximately 20 people. The public is welcome to participate during the public comment, which is tentatively scheduled from 2:45 p.m. to 2:55 p.m., EDT. To participate on the teleconference, please dial 866–917–2712 and enter code 9418625. PURPOSE: The Subcommittee will provide advice to the ACD on strategies, future needs, and challenges faced by State, Tribal, Local and Territorial health agencies, and will provide guidance on opportunities for CDC through the ACD. MATTERS FOR DISCUSSION: The STLT Subcommittee members will discuss progress on implementation of ACDadopted recommendations related to the health department of the future, other emerging challenges and how CDC can best support STLT health departments in the transforming health system. The agenda is subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: ´ Jose Montero, MD, Designated Federal Officer, STLT Subcommittee, ACD, CDC, 4770 Buford Highway, MS E70, Atlanta, GA 30341, Telephone (404) 498–0259, email: OSTLTSDirector@ cdc.gov. Please submit comments to OSTLTSDirector@cdc.gov no later than August 4, 2017. Jkt 241001 National Institutes of Health [FR Doc. 2017–13339 Filed 6–26–17; 8:45 am] Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—State, Tribal, Local and Territorial (STLT) Subcommittee 18:33 Jun 26, 2017 [FR Doc. 2017–13358 Filed 6–26–17; 8:45 am] Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–13414 Filed 6–26–17; 8:45 am] VerDate Sep<11>2014 Dated: June 21, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Biomarkers and Bio Specimens. Date: July 27, 2017. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892–9750 (Telephone Conference Call). Contact Person: Reed A. Graves, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892– 9750 240–276–6384, gravesr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; ‘‘Relationship between Delirium and Alzheimer’s disease’’. Date: July 21, 2017. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 2C223, 7201 Wisconsin Ave., Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Isis S. Mikhail, MD, MPH, DRPH, National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301–402–7704, Mikhaili@Mail.NIH.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: June 21, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–13360 Filed 6–26–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Disease; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as E:\FR\FM\27JNN1.SGM 27JNN1

Agencies

[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Page 29088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13339]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention--State, Tribal, Local and Territorial (STLT) 
Subcommittee

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
subcommittee:

Time and Date:  8:30 a.m.-3:30 p.m., EDT, August 11, 2017.

Place:  CDC, Building 19, Rooms 245-246, 1600 Clifton Road, NE., 
Atlanta, Georgia 30329. This meeting will also be held by 
teleconference.

Status:  Open to the public, limited only by the space available. The 
meeting room accommodates approximately 20 people. The public is 
welcome to participate during the public comment, which is tentatively 
scheduled from 2:45 p.m. to 2:55 p.m., EDT. To participate on the 
teleconference, please dial 866-917-2712 and enter code 9418625.

Purpose:  The Subcommittee will provide advice to the ACD on 
strategies, future needs, and challenges faced by State, Tribal, Local 
and Territorial health agencies, and will provide guidance on 
opportunities for CDC through the ACD.

Matters for Discussion:  The STLT Subcommittee members will discuss 
progress on implementation of ACD-adopted recommendations related to 
the health department of the future, other emerging challenges and how 
CDC can best support STLT health departments in the transforming health 
system.
    The agenda is subject to change as priorities dictate.

Contact Person for More Information:  Jos[eacute] Montero, MD, 
Designated Federal Officer, STLT Subcommittee, ACD, CDC, 4770 Buford 
Highway, MS E70, Atlanta, GA 30341, Telephone (404) 498-0259, email: 
OSTLTSDirector@cdc.gov. Please submit comments to 
OSTLTSDirector@cdc.gov no later than August 4, 2017.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-13339 Filed 6-26-17; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.